Nautilus Biotechnolgy
NAUT
NAUT
66 hedge funds and large institutions have $48.9M invested in Nautilus Biotechnolgy in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
72% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 29
Holders
66
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$328K | |
| 2 | +$145K | |
| 3 | +$126K | |
| 4 |
CA
Crewe Advisors
Salt Lake City,
Utah
|
+$115K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$69.5K |
Top Sellers
| 1 | -$451K | |
| 2 | -$361K | |
| 3 | -$203K | |
| 4 |
Goldman Sachs
New York
|
-$167K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$163K |
